Inova Software Reaps the Benefits of its New Business Model

Share this on Facebook Share this on Twitter Share this on LinkedIn

Inova Software, software editor of a CRM dedicated to pharmaceutical companies, has followed software trends, moving into a SaaS model. “The technological shift represents a dual strategy,” explained Gilles Toulemonde, Inova CEO, “to generate recurrent revenues and to adapt ourselves to new clients, such as small biotechs who prefer this model.” The drawback: the turnover suffered during the transition period. “The breakeven point will be reached in October, and then we will experience a period of growth.” Today, two-thirds of Inova’s 70 clients have made the switch to SaaS.

Inova Software counts among its clients Sanofi, AstraZeneca, Boehringer-Ingelheim, Bayer, Merck, Pierre Fabre, Roche and Takeda. Based in Lyon and New York, 80% of its sales occur internationally. The company recruited 6 new people in Lyon and New York in 2015 and signed 20 new clients including two Top 10 American pharmas, the Swiss pharmaceutical company, Ferring, French companies the Centre Leon Berard and Expanscience, as well as biotechs such as Innate Pharma, New Link Genetics and Chimerix. Inova is currently recruiting 5 new colleagues this year.

This article originally appeared in Bref Rhône-Alpes Auvergne and has been translated from French. To view the original article visit here.

Further reading

Company News

The Inova Partnering for Innovation Seminar: Meeting at the crossroads of innovation, technology and partnering

A couple weeks ago, Inova Software hosted a seminar on Partnering for Innovation, providing an oppor...

Read more
Product

What's new in Inova Software : September 2018

Welcome to our September edition of What's new in Inova!This month instead of looking at what’...

Read more
Company News

Virtual partnering event launched to accelerate partnerships in the life sciences industry to fight against COVID-19

COVID-19 Virtual Partnering is a unique and free-to-attend virtual event taking place on 20 Apri...

Read more